| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/29/2007 | WO2007035760A1 Enhanced solubility of preformed calcium citrate by adding citric acid |
| 03/29/2007 | WO2007035515A2 A method of intraepithelial and systemic exposure of therapeutic agents following vaginal and oral cavity administration |
| 03/29/2007 | WO2007035348A2 Nanoparticulate aripiprazole formulations |
| 03/29/2007 | WO2007035336A2 Effervescent rehydrating beverage tablet/granules |
| 03/29/2007 | WO2007035311A2 Anti-oxidant synergy formulation nanoemulsions to treat cancer |
| 03/29/2007 | WO2007035117A1 Oral vehicle for systemic pharmaceuticals |
| 03/29/2007 | WO2007034807A1 Dipeptide-containing composition for oral administration |
| 03/29/2007 | WO2007034741A1 Anti-viral agent, and method for treatment of virus-infected cell |
| 03/29/2007 | WO2007034736A1 Adhesive skin patch |
| 03/29/2007 | WO2007034586A1 Photocatalytic titanium dioxide microparticle, dispersion liquid thereof and process for producing the same |
| 03/29/2007 | WO2007034219A2 Modifying leukocyte function |
| 03/29/2007 | WO2007034140A1 Chronotherapeutic ocular delivery system comprising a combination of prostaglandin and a beta-blocker for treating primary glaucoma |
| 03/29/2007 | WO2007034135A1 Composition comprising a nsaid and paracetamol |
| 03/29/2007 | WO2007034022A1 Composition for administration to mammals or humans |
| 03/29/2007 | WO2007033677A1 Aryl/alkyl succinic anhydride hyaluronan derivatives |
| 03/29/2007 | WO2007033522A1 Capsule formulation containing moxifloxacin and its preparation method |
| 03/29/2007 | WO2007033515A1 Oral formulation containing moxifloxacin and its preparation method |
| 03/29/2007 | WO2007016284A3 Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily |
| 03/29/2007 | WO2007012837A3 Compositions for treating psychiatric conditions |
| 03/29/2007 | WO2007011989A3 Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 03/29/2007 | WO2007010337A3 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 03/29/2007 | WO2007008427A3 Aerosol compositions and methods |
| 03/29/2007 | WO2007006885A3 Method for producing a powder containing xylitol crystal particles with another polyol |
| 03/29/2007 | WO2007003447A3 Coated granular formulations |
| 03/29/2007 | WO2007002318A3 Bioadhesive polymers |
| 03/29/2007 | WO2007000778A3 Modified release pharmaceutical compositions on the basis of two polymers and processes thereof |
| 03/29/2007 | WO2007000591A3 Antimicrobial materials |
| 03/29/2007 | WO2006135854A3 Antiseptic compositions |
| 03/29/2007 | WO2006132995A3 Particle size, percent drag efficiency and molecular weight control of bulk polymer polymerized polyalphaolefins using high shear material processors |
| 03/29/2007 | WO2006131737A3 Method and composition for treating inflammatory disorders |
| 03/29/2007 | WO2006128907A3 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation |
| 03/29/2007 | WO2006127355A3 Oral drug compliance monitoring using radio frequency identification tags |
| 03/29/2007 | WO2006125978A3 Assay particles |
| 03/29/2007 | WO2006120705A3 Treatment and control of severe infections including cystic fibrosis |
| 03/29/2007 | WO2006116661A3 Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals |
| 03/29/2007 | WO2006108949A3 Novel use of zinc gluconate for treating hydradenitis suppurativa |
| 03/29/2007 | WO2006102964A3 Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
| 03/29/2007 | WO2006102378A3 Drug delivery systems for treatment of diseases or conditions |
| 03/29/2007 | WO2006092732A3 Stable solid dosage form of antihypertensive agent |
| 03/29/2007 | WO2006081293A3 Delivery of bio-available compounds with anhydrous topical preparations |
| 03/29/2007 | WO2006062883A3 Medical combinations |
| 03/29/2007 | WO2006044771A3 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 03/29/2007 | WO2006028533A3 Candle using solidified skin care agents for fuel, and providing skin care liquid as an operational end product |
| 03/29/2007 | WO2005107689A3 Cleansing and rinse solutions for skin and hair and method of using |
| 03/29/2007 | WO2005105038A3 A system and a method for producing layered oral dosage forms |
| 03/29/2007 | WO2005087199A8 Stabilised supersaturated solid solutions of steroidal drugs |
| 03/29/2007 | US20070073273 Device and process for metering solutions |
| 03/29/2007 | US20070073016 Polymer compositions for intraluminal stent |
| 03/29/2007 | US20070072937 Pharmaceutical composition comprising alpha-lipoic acid for inflammatory diseases |
| 03/29/2007 | US20070072827 Insecticide formulation |
| 03/29/2007 | US20070072826 Compositions and methods for modulation of vascular structure and/or function |
| 03/29/2007 | US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070071834 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 03/29/2007 | US20070071830 Method for increasing bioavailability of lipophilic bioactive compounds |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071826 Method for preparing nano-scale or amorphous particle using solid fat as a solvent |
| 03/29/2007 | US20070071825 Device and method for making particles |
| 03/29/2007 | US20070071824 Treatment of mucositis using N-acetylcysteine |
| 03/29/2007 | US20070071823 complexing amphoteric polymers with polynucleotides and delivering the complex into cells |
| 03/29/2007 | US20070071822 Film coated tablet for improved upper gastrointestinal tract safety |
| 03/29/2007 | US20070071821 Formulation for providing an enteric coating material |
| 03/29/2007 | US20070071820 Delayed release pharmaceutical formulations |
| 03/29/2007 | US20070071819 Multiple unit modified release compositions of carbamazepine and process for their preparation |
| 03/29/2007 | US20070071818 Effervescent formulations comprising apomorphine |
| 03/29/2007 | US20070071817 Effervescent oral care compositions and method of use |
| 03/29/2007 | US20070071816 Oral drug delivery system |
| 03/29/2007 | US20070071815 Oral formulation of creatine derivatives and method of manufacturing same |
| 03/29/2007 | US20070071814 Vaginal tablets comprising misoprostol and methods of making and using the same |
| 03/29/2007 | US20070071813 Novel dosage formulation |
| 03/29/2007 | US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 03/29/2007 | US20070071811 Stable combinations of amlodipine besylate and benazepril hydrochloride |
| 03/29/2007 | US20070071810 Additive for tablets |
| 03/29/2007 | US20070071809 Ginger containing compositions to control pain |
| 03/29/2007 | US20070071808 Capsule filled with honey |
| 03/29/2007 | US20070071807 Capsule-type drug-releasing device and capsule-type drug-releasing device system |
| 03/29/2007 | US20070071806 Tansmucosal drug delivery system |
| 03/29/2007 | US20070071805 Treatment of inflammation and vascular abnormalities of the eye |
| 03/29/2007 | US20070071804 Compositions and methods of preparation of liposomal microparticulate IL-12 |
| 03/29/2007 | US20070071803 Dermal penetration enhancers and drug delivery systems involving same |
| 03/29/2007 | US20070071802 Topical anesthetic for dental procedures |
| 03/29/2007 | US20070071801 Bandage which carries a topical agent to facilitate treatment of infections; absorption of a skin abscess exudate while protecting the skin surrounding the treatment area |
| 03/29/2007 | US20070071798 Perforated bioabsorbable oil film and methods for making the same |
| 03/29/2007 | US20070071797 Lotioned fibrous structures |
| 03/29/2007 | US20070071796 Administration form based on cross-linked hydrophilic polymers |
| 03/29/2007 | US20070071789 Bioactive Material Delivery Systems Comprising Sol-Gel Compositions |
| 03/29/2007 | US20070071787 Composite material comprising a porous semiconductor impregnated with an organic substance |
| 03/29/2007 | US20070071779 Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof |
| 03/29/2007 | US20070071778 Stable microemulsion concentrate for delivery of a bioactive biocide/disinfectant/fungicide/fragrance in an aqueous medium providing sustained release |
| 03/29/2007 | US20070071777 Oil emulsion for postnatal hormone substitution |
| 03/29/2007 | US20070071768 RNAIII-inhibiting peptide (RIP) with antimicrobial peptide such as cathelicidin, capable of binding and neutralizing lipidic and polyanionic components of bacterial cell envelope; infections from Staphylococcus and Bacillus; antibiotic resistance; cellulitis, keratitis, osteomyelitis, septic arthrititis |
| 03/29/2007 | US20070071733 Synthetic substrate for tissue formation |
| 03/29/2007 | US20070071711 Formulations for topical delivery of bioactive substances and methods for their use |
| 03/29/2007 | US20070071692 Aerosol powder formulation |
| 03/29/2007 | US20070071691 Composition |
| 03/29/2007 | US20070071690 Dry powder formulations |
| 03/29/2007 | US20070071688 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents |
| 03/29/2007 | US20070071687 Intranasal benzodiazepine compositions |
| 03/29/2007 | US20070071686 Liquid preparation containing tobramycin |
| 03/29/2007 | US20070071684 Process for the preparation of surface coatings and films |